Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-7drxs Total loading time: 0 Render date: 2024-07-23T08:23:25.775Z Has data issue: false hasContentIssue false

References

Published online by Cambridge University Press:  10 October 2009

Ken Uchino ,
Jennifer Pary  and
James Grotta
Ken Uchino
Affiliation:
University of Texas, Houston
Jennifer Pary
Affiliation:
University of Texas, Houston
James Grotta
Affiliation:
University of Texas, Houston
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Acute Stroke Care
A Manual from the University of Texas - Houston Stroke Team
 , pp. 203 - 213
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adams, H. P. Jr., Adams, R. J., Brott, T., et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003; 34: 1056–83.CrossRefGoogle ScholarPubMed
Adams, H., Adams, R., Del Zoppo, G., & Goldstein, L. B.Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update. A Scientific Statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005; 36: 916–23.CrossRefGoogle ScholarPubMed
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997; 349: 1569–81.CrossRef
CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997; 349: 1641–9.CrossRef
Berge, E., Abdelnoor, M., Nakstad, P. H., & Sandset, P. M.Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet 2000; 355: 1205–10.CrossRefGoogle Scholar
Hart, R. G., Palacio, S., & Pearce, L. A.Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials. Stroke 2002; 33: 2722–7.CrossRefGoogle ScholarPubMed
Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., & Teal, P.Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 suppl.): 483S–512S. http://www.chestjournal.org/cgi/reprint/126/3_suppl/483S.CrossRefGoogle ScholarPubMed
Adams, H. P. Jr., Bendixen, B. H., Kappelle, L. J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35–41.CrossRefGoogle Scholar
U-King-Im, J. M., Trivedi, R. A., Graves, M. J., et al. Contrast-enhanced MR angiography for carotid disease: diagnostic and potential clinical impact. Neurology 2004; 62: 1282–90.CrossRefGoogle ScholarPubMed
Petty, G. W., Brown, R. D. Jr., Whisnant, J. P., Sicks, J. D., O'Fallon, W. M., & Wiebers, D. O.Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology 1998; 50: 208–16.CrossRefGoogle ScholarPubMed
Hartmann, A., Rundek, T., Mast, H., et al. Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology 2001; 57: 2000–5.CrossRefGoogle ScholarPubMed
Bravata, D. M., Ho, S. Y., Brass, L. M., Concato, J., Scinto, J., & Meehan, T. P.Long-term mortality in cerebrovascular disease. Stroke 2003; 34: 699–704.CrossRefGoogle ScholarPubMed
Dewey, H. M., Sturm, J., Donnan, G. A., Macdonell, R. A., McNeil, J. J., & Thrift, A. G.Incidence and outcome of subtypes of ischaemic stroke: initial results from the North East Melbourne stroke incidence study (NEMESIS). Cerebrovasc. Dis. 2003; 15: 133–9.CrossRefGoogle Scholar
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 1995; 333: 1581–7.CrossRef
Marler, J. R., Tilley, B. C., Lu, M., et al. Early stroke treatment associated with better outcome: the National Institute of Neurological Disorders and Stroke rt-PA stroke study. Neurology 2000; 55: 1649–55.CrossRefGoogle Scholar
Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. Stroke 1997; 28: 2119–25.CrossRef
Patel, S. C., Levine, S. R., Tilley, B. C., et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA 2001; 286: 2830–8.CrossRefGoogle ScholarPubMed
Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004; 35: 904–11.CrossRef
Hacke, W., Donnan, G., Fieschi, C., et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and National Institute of Neurological Disorders and Stroke rt-PA stroke trials. Lancet 2004; 363: 768–74.Google Scholar
Smith, W. C., Sung, G., Starkman, S., et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36: 1432–8.CrossRefGoogle ScholarPubMed
Saxena, R., Lewis, S., Berge, E., Sandercock, P. A., & Koudstaal, P. J.Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke 2001; 32: 2333–7.CrossRefGoogle ScholarPubMed
Kang, D. W., Latour, L. L., Chalela, J. A., Dambrosia, J., & Warach, S.Early ischemic lesion recurrence within a week after acute ischemic stroke. Ann. Neurol. 2003; 54: 66–74.CrossRefGoogle ScholarPubMed
Lovett, J. K., Coull, A. J., & Rothwell, P. M.Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004; 62: 569–73.CrossRefGoogle ScholarPubMed
Fiorelli, M., Bastianello, S., Kummer, R., et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999; 30: 2280–4.CrossRefGoogle ScholarPubMed
Lees, K. R., Zivin, J. A., Ashwood, T., et al. for the Stroke–Acute Ischemic NXY Treatment (SAINT I) Trial Investigators. NXY-059 for acute ischemic stroke. N. Engl. J. Med. 2006; 354: 588–600.CrossRefGoogle ScholarPubMed
Schneider, L. S., Dagerman, K. S., & Insel, P.Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005; 294: 1934–43.CrossRefGoogle ScholarPubMed
Sacco, R. L., Adams, R., Albers, G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke 2006; 37: 577–617.CrossRefGoogle ScholarPubMed
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255–64.CrossRef
Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R., & Dagenais, G.Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 2000; 342: 145–53.Google Scholar
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033–41.CrossRef
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981–97.CrossRef
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7–22.CrossRef
Grundy, S. M., Cleeman, J. I., Merz, C. N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227–39.CrossRefGoogle ScholarPubMed
Toole, J. F., Malinow, M. R., Chambless, L. E., et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004; 291: 565–75.CrossRefGoogle ScholarPubMed
Viscoli, C. M., Brass, L. M., Kernan, W. N., Sarrel, P. M., Suissa, S., & Horwitz, R. I.A clinical trial of estrogen-replacement therapy after ischemic stroke. N. Engl. J. Med. 2001; 345: 1243–9.CrossRefGoogle ScholarPubMed
Anderson, G. L., Limacher, M., Assaf, A. R., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291: 1701–12.Google ScholarPubMed
Rossouw, J. E., Anderson, G. L., Prentice, R. L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–33.Google ScholarPubMed
Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81–106.CrossRef
Diener, H. C., Cunha, L., Forbes, C., Sivenius, J., Smets, P., & Lowenthal, A.European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J. Neurol. Sci. 1996; 143: 1–13.CrossRefGoogle ScholarPubMed
The ESPS Group. The European Stroke Prevention Study (ESPS): principal end-points. Lancet 1987; 2: 1351–4.
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329–39.CrossRef
Diener, H. C., Bogousslavsky, J., Brass, L. M., et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 331–7.CrossRefGoogle ScholarPubMed
Bhatt, D. L., Fox, K. A. A., Hacke, W., et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N. Engl. J. Med. 2006; 354: 1706–17.CrossRefGoogle ScholarPubMed
Hart, R. G., Halperin, J. L., Pearce, L. A., et al. Lessons from the Stroke Prevention in Atrial Fibrillation trials. Ann. Intern. Med. 2003; 138: 831–8.CrossRefGoogle ScholarPubMed
Saxena, R. & Koudstaal, P.Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack. Cochrane Database Syst. Rev. 2004(4): CD000187.Google ScholarPubMed
Ferro, J. M.Cardioembolic stroke: an update. Lancet Neurol. 2003; 2: 177–88.CrossRefGoogle ScholarPubMed
Amarenco, P., Cohen, A., Tzourio, C., et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N. Engl. J. Med. 1994; 331: 1474–9.CrossRefGoogle ScholarPubMed
Blackshear, J. L., Zabalgoitia, M., Pennock, G., et al. Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation. SPAF transesophageal echocardiogram Investigators. Stroke Prevention and Atrial Fibrillation. Transesophageal echocardiography. Am. J. Cardiol. 1999; 83: 453–5, A9.CrossRefGoogle ScholarPubMed
Mohr, J. P.Anticoagulation for stroke prevention: yes, no, maybe. Cleve. Clin. J. Med. 2004; 71 (Suppl. 1): S52–6.CrossRefGoogle ScholarPubMed
Homma, S., Sacco, R. L., Di Tullio, M. R., Sciacca, R. R., & Mohr, J. P.Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002; 105: 2625–31.CrossRefGoogle ScholarPubMed
Chimowitz, M. I., Lynn, M. J., Howlett-Smith, H., et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N. Engl. J. Med. 2005; 352: 1305–16.CrossRefGoogle ScholarPubMed
Mohr, J. P., Thompson, J. L., Lazar, R. M., et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N. Engl. J. Med. 2001; 345: 1444–51.CrossRefGoogle ScholarPubMed
Levine, S. R., Brey, R. L., Tilley, B. C., et al. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004; 291: 576–84.Google ScholarPubMed
Chobanian, A. V., Bakris, G. L., Black, H. R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560–72.CrossRefGoogle ScholarPubMed
Dahlof, B., Devereux, R. B., Kjeldsen, S. E., et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995–1003.CrossRefGoogle ScholarPubMed
Psaty, B. M., Lumley, T., Furberg, C. D., et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003; 289: 2534–44.CrossRefGoogle ScholarPubMed
Barnett, H. J.Decision-making for carotid endarterectomy: the trials are only the start. Can. J. Neurol. Sci. 2002; 29: 302–4.CrossRefGoogle ScholarPubMed
Barnett, H. J., Taylor, D. W., Eliasziw, M., et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N. Engl. J. Med. 1998; 339: 1415–25.CrossRefGoogle ScholarPubMed
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273: 1421–8.CrossRef
Halliday, A., Mansfield, A., Marro, J., et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004; 363: 1491–502.Google ScholarPubMed
Yadav, J. S., Wholey, M. H., Kuntz, R. E., et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N. Engl. J. Med. 2004; 351: 1493–501.CrossRefGoogle ScholarPubMed
Rothwell, P. M., Eliasziw, M., Gutnikov, S. A., Warlow, C. P., & Barnett, H. J.Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363: 915–24.CrossRefGoogle ScholarPubMed
Rothwell, P. M., Eliasziw, M., Gutnikov, S. A., Warlow, C. P., & Barnett, H. J.Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke. Stroke 2004; 35: 2855–61.CrossRefGoogle ScholarPubMed
Bond, R., Rerkasem, K., & Rothwell, P. M.Systematic review of the risks of carotid endarterectomy in relation to the clinical indication for and timing of surgery. Stroke 2003; 34: 2290–301.CrossRefGoogle ScholarPubMed
Grubb, R. L. Jr., Powers, W. J., Derdeyn, C. P., Adams, H. P. Jr., & Clarke, W. R.The carotid occlusion surgery study. Neurosurg. Focus 2003; 14 (3): e9.CrossRefGoogle ScholarPubMed
Grubb, R. L. Jr., Derdeyn, C. P., Fritsch, S. M., et al. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998; 280: 1055–60.CrossRefGoogle ScholarPubMed
Vernieri, F., Pasqualetti, P., Passarelli, F., Rossini, P. M., & Silvestrini, M.Outcome of carotid artery occlusion is predicted by cerebrovascular reactivity. Stroke 1999; 30: 593–8.CrossRefGoogle ScholarPubMed
Yonemura, K., Kimura, K., Minematsu, K., Uchino, M., & Yamaguchi, T.Small centrum ovale infarcts on diffusion-weighted magnetic resonance imaging. Stroke 2002; 33: 1541–4.CrossRefGoogle ScholarPubMed
Landau, W. M.Clinical neuromythology VI. Au clair de lacune: holy, wholly, holey logic. Neurology 1989; 39: 725–30.CrossRefGoogle ScholarPubMed
Perry, H. M. Jr., Davis, B. R., Price, T. R., et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA 2000; 284: 465–71.CrossRefGoogle Scholar
Chen, C. J., Tseng, Y. C., Lee, T. H., Hsu, H. L., & See, L. C.Multisection computed tomography angiography compared with catheter angiography in diagnosing vertebral artery dissection. AJNR Am. J. Neuroradiol. 2004; 25: 769–74.Google ScholarPubMed
Touze, E., Gauvrit, J. Y., Moulin, T., Meder, J. F., Bracard, S., & Mas, J. L.Risk of stroke and recurrent dissection after a cervical artery dissection: a multicenter study. Neurology 2003; 61: 1347–51.CrossRefGoogle ScholarPubMed
Overell, J. R., Bone, I., & Lees, K. R.Interatrial septal abnormalities and stroke: a meta-analysis of case–control studies. Neurology 2000; 55: 1172–9.CrossRefGoogle ScholarPubMed
Messe, S. R., Silverman, I. E., Kizer, J. R., et al. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004; 62: 1042–50.CrossRefGoogle ScholarPubMed
Albers, G. W., Caplan, L. R., Easton, J. D., et al. Transient ischemic attack: proposal for a new definition. N. Engl. J. Med. 2002; 347: 1713–16.CrossRefGoogle ScholarPubMed
Johnston, S. C., Gress, D. R., Browner, W. S., & Sidney, S.Short-term prognosis after emergency department diagnosis of transient ischemic attack. JAMA 2000; 284: 2901–6.CrossRefGoogle Scholar
Johnston, S. C. & Sidney, S.Validation of a 4-point prediction rule to stratify short-term stroke risk after transient ischemic attack [abstract]. Stroke 2005; 36: 430. [Presentation, International Stroke Meeting, February 2006.]Google Scholar
Qureshi, A. I., Tuhrim, S., Broderick, J. P., Batjer, H. H., Hondo, H., & Hanley, D. F.Spontaneous intracerebral hemorrhage. N. Engl. J. Med. 2001; 344: 1450–60.CrossRefGoogle ScholarPubMed
Mendelow, A. D., Gregson, B. A., Fernandes, H. M., et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005; 365: 387–97.CrossRefGoogle ScholarPubMed
Broderick, J. P., Adams, H. P. Jr., Barsan, W., et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999; 30: 905–15.CrossRefGoogle ScholarPubMed
Brott, T., Broderick, J., Kothari, R., et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28: 1–5.CrossRefGoogle ScholarPubMed
Mayer, S. A., Brun, N. C., Begtrup, K., et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N. Engl. J. Med. 2005; 352: 777–85.CrossRefGoogle ScholarPubMed
Broderick, J. P., Brott, T. G., Duldner, J. E., Tomsick, T., & Huster, G.Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke 1993; 24: 987–93.CrossRefGoogle ScholarPubMed
Hemphill, J. C., Bonovich, D. C., Besmertis, L., Manley, G. T., & Johnston, S. C.The intracerebral hemorrhage score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001; 32: 891–7.CrossRefGoogle ScholarPubMed
Mayberg, M. R., Batjer, H. H., Dacey, R.et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994; 25: 2315–28.CrossRefGoogle ScholarPubMed
Molyneux, A., Kerr, R., Stratton, I., et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002; 360: 1267–74.CrossRefGoogle ScholarPubMed
Bergh, W. M., Algra, A., Kooten, F., et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 2005; 36: 1011–15.CrossRefGoogle ScholarPubMed
Longstreth, W. T. Jr., Nelson, L. M., Koepsell, T. D., & Belle, G.Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington. Neurology 1993; 43: 712–18.CrossRefGoogle ScholarPubMed
Kassell, N. F., Torner, J. C., Jane, J. A., Haley, E. C. Jr., & Adams, H. P.The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: surgical results. J. Neurosurg. 1990; 73: 37–47.CrossRefGoogle ScholarPubMed
International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: risk of rupture and risks of surgical intervention. N. Engl. J. Med. 1998; 339: 1725–33.CrossRef
Wiebers, D. O., Whisnant, J. P., Huston, J., et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003; 362: 103–10.CrossRefGoogle ScholarPubMed
Brainin, M., Olsen, T. S., Chamorro, A., et al. Organization of stroke care: education, referral, emergency management and imaging, stroke units and rehabilitation. European Stroke Initiative. Cerebrovasc. Dis. 2004; 17 (Suppl. 2): 1–14.CrossRefGoogle ScholarPubMed
Hack, W., Kaste, M., Bogousslavsky, J., et al. European Stroke Initiative Recommendations for Stroke Management: update 2003. Cerebrovasc. Dis. 2003; 16: 311–37.Google Scholar
Schwamm, L. H., Pancioli, A., Acker, J. E., et al. Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke 2005; 36: 690–703.Google ScholarPubMed
Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst. Rev. 2002 (1): CD000197.
Alberts, M. J., Hademenos, G., Latchaw, R. E., et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 2000; 283: 3102–9.CrossRefGoogle ScholarPubMed
Duncan, P. W., Zorowitz, R., Bates, B., et al.. Management of adult stroke rehabilitation care: a clinical practice guideline. Stroke 2005; 36: e100–43.CrossRefGoogle ScholarPubMed
Tepel, M., Giet, M., Schwarzfeld, C., Laufer, U., Liermann, D., & Zidek, W.Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N. Engl. J. Med. 2000; 343: 180–4.CrossRefGoogle ScholarPubMed
Kay, J., Chow, W. H., Chan, T. M., et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 2003; 289: 553–8.CrossRefGoogle ScholarPubMed
Merten, G. J., Burgess, W. P., Gray, L. V., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; 291: 2328–34.CrossRefGoogle ScholarPubMed
Barber, P. A., Demchuk, A. M., Zhang, J., & Buchan, A. M.Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early computed tomography Score. Lancet 2000; 355: 1670–4.CrossRefGoogle Scholar
Eastwood, J. D., Engelter, S. T., MacFall, J. F., Delong, D. M., & Provenzale, J. M.Quantitative assessment of the time course of infarct signal intensity on diffusion-weighted images. AJNR Am. J. Neuroradiol. 2003; 24: 680–7.Google ScholarPubMed
Parizel, P. M., Makkat, S., Miert, E., Goethem, J. W., Hauwe, L., & Schepper, A. M.Intracranial hemorrhage: principles of computed tomography and magnetic resonance imaging interpretation. Eur. Radiol. 2001; 11: 1770–83.CrossRefGoogle Scholar
Alexandrov, A. V.Cerebrovascular Ultrasound in Stroke Prevention and Treatment: Elmsford, NY; Oxford: Blackwell/Futura, 2004.CrossRefGoogle Scholar
Angeli, S., Del Sette, M., Beelke, M., Anzola, G. P., & Zanette, E.Transcranial Doppler in the diagnosis of cardiac patent foramen ovale. Neurol. Sci. 2001; 22: 353–6.CrossRefGoogle Scholar
Jauss, M. & Zanette, E.Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc. Dis. 2000; 10: 490–6.CrossRefGoogle ScholarPubMed
Toth, C. & Voll, C.Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke. Stroke 2002; 33: 670–4.CrossRefGoogle ScholarPubMed
Hillbom, M., Erila, T., Sotaniemi, K., Tatlisumak, T., Sarna, S., & Kaste, M.Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study. Acta Neurol. Scand. 2002; 106: 84–92.CrossRefGoogle ScholarPubMed
Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. A definition of irreversible coma. JAMA 1968; 205: 337–40.CrossRef
Teasdale, G. & Jennett, B.Assessment of coma and impaired consciousness: a practical scale. Lancet 1974; 2: 81–4.CrossRefGoogle ScholarPubMed
Hunt, W. E. & Hess, R. M.Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J. Neurosurg. 1968; 28: 14–20.CrossRefGoogle ScholarPubMed
Teasdale, G. M., Drake, C. G., Hunt, W., et al. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J. Neurol. Neurosurg. Psychiatry 1988; 51: 1457.CrossRefGoogle ScholarPubMed
Rankin, J.Cerebral vascular accidents in patients over the age of 60. Scott. Med. J. 1957; 2: 200–15.CrossRefGoogle ScholarPubMed
Bonita, R. & Beaglehole, R.Modification of Rankin scale: recovery of motor function after stroke. Stroke 1988; 19: 1497–500.CrossRefGoogle Scholar
Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J., & Gijn, J.Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604–7.CrossRefGoogle ScholarPubMed
Goldstein, L. B., Bertels, C., & Davis, J. N.Interrater reliability of the National Institutes of Health stroke scale. Arch. Neurol. 1989; 46: 660–2.CrossRefGoogle Scholar
Lyden, P., Raman, R., Liu, L., et al. National Institutes of Health Stroke Scale training and certification using a new digital video disk is reliable. Stroke 2005; 36: 2446–9.CrossRefGoogle ScholarPubMed
Adams, H. P. Jr., Adams, R. J., Brott, T., et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003; 34: 1056–83.CrossRefGoogle ScholarPubMed
Adams, H., Adams, R., Del Zoppo, G., & Goldstein, L. B.Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update. A Scientific Statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005; 36: 916–23.CrossRefGoogle ScholarPubMed
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997; 349: 1569–81.CrossRef
CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997; 349: 1641–9.CrossRef
Berge, E., Abdelnoor, M., Nakstad, P. H., & Sandset, P. M.Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet 2000; 355: 1205–10.CrossRefGoogle Scholar
Hart, R. G., Palacio, S., & Pearce, L. A.Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials. Stroke 2002; 33: 2722–7.CrossRefGoogle ScholarPubMed
Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., & Teal, P.Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 suppl.): 483S–512S. http://www.chestjournal.org/cgi/reprint/126/3_suppl/483S.CrossRefGoogle ScholarPubMed
Adams, H. P. Jr., Bendixen, B. H., Kappelle, L. J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35–41.CrossRefGoogle Scholar
U-King-Im, J. M., Trivedi, R. A., Graves, M. J., et al. Contrast-enhanced MR angiography for carotid disease: diagnostic and potential clinical impact. Neurology 2004; 62: 1282–90.CrossRefGoogle ScholarPubMed
Petty, G. W., Brown, R. D. Jr., Whisnant, J. P., Sicks, J. D., O'Fallon, W. M., & Wiebers, D. O.Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology 1998; 50: 208–16.CrossRefGoogle ScholarPubMed
Hartmann, A., Rundek, T., Mast, H., et al. Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology 2001; 57: 2000–5.CrossRefGoogle ScholarPubMed
Bravata, D. M., Ho, S. Y., Brass, L. M., Concato, J., Scinto, J., & Meehan, T. P.Long-term mortality in cerebrovascular disease. Stroke 2003; 34: 699–704.CrossRefGoogle ScholarPubMed
Dewey, H. M., Sturm, J., Donnan, G. A., Macdonell, R. A., McNeil, J. J., & Thrift, A. G.Incidence and outcome of subtypes of ischaemic stroke: initial results from the North East Melbourne stroke incidence study (NEMESIS). Cerebrovasc. Dis. 2003; 15: 133–9.CrossRefGoogle Scholar
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 1995; 333: 1581–7.CrossRef
Marler, J. R., Tilley, B. C., Lu, M., et al. Early stroke treatment associated with better outcome: the National Institute of Neurological Disorders and Stroke rt-PA stroke study. Neurology 2000; 55: 1649–55.CrossRefGoogle Scholar
Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. Stroke 1997; 28: 2119–25.CrossRef
Patel, S. C., Levine, S. R., Tilley, B. C., et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA 2001; 286: 2830–8.CrossRefGoogle ScholarPubMed
Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004; 35: 904–11.CrossRef
Hacke, W., Donnan, G., Fieschi, C., et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and National Institute of Neurological Disorders and Stroke rt-PA stroke trials. Lancet 2004; 363: 768–74.Google Scholar
Smith, W. C., Sung, G., Starkman, S., et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36: 1432–8.CrossRefGoogle ScholarPubMed
Saxena, R., Lewis, S., Berge, E., Sandercock, P. A., & Koudstaal, P. J.Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke 2001; 32: 2333–7.CrossRefGoogle ScholarPubMed
Kang, D. W., Latour, L. L., Chalela, J. A., Dambrosia, J., & Warach, S.Early ischemic lesion recurrence within a week after acute ischemic stroke. Ann. Neurol. 2003; 54: 66–74.CrossRefGoogle ScholarPubMed
Lovett, J. K., Coull, A. J., & Rothwell, P. M.Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004; 62: 569–73.CrossRefGoogle ScholarPubMed
Fiorelli, M., Bastianello, S., Kummer, R., et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999; 30: 2280–4.CrossRefGoogle ScholarPubMed
Lees, K. R., Zivin, J. A., Ashwood, T., et al. for the Stroke–Acute Ischemic NXY Treatment (SAINT I) Trial Investigators. NXY-059 for acute ischemic stroke. N. Engl. J. Med. 2006; 354: 588–600.CrossRefGoogle ScholarPubMed
Schneider, L. S., Dagerman, K. S., & Insel, P.Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005; 294: 1934–43.CrossRefGoogle ScholarPubMed
Sacco, R. L., Adams, R., Albers, G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke 2006; 37: 577–617.CrossRefGoogle ScholarPubMed
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255–64.CrossRef
Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R., & Dagenais, G.Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 2000; 342: 145–53.Google Scholar
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033–41.CrossRef
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981–97.CrossRef
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7–22.CrossRef
Grundy, S. M., Cleeman, J. I., Merz, C. N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227–39.CrossRefGoogle ScholarPubMed
Toole, J. F., Malinow, M. R., Chambless, L. E., et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004; 291: 565–75.CrossRefGoogle ScholarPubMed
Viscoli, C. M., Brass, L. M., Kernan, W. N., Sarrel, P. M., Suissa, S., & Horwitz, R. I.A clinical trial of estrogen-replacement therapy after ischemic stroke. N. Engl. J. Med. 2001; 345: 1243–9.CrossRefGoogle ScholarPubMed
Anderson, G. L., Limacher, M., Assaf, A. R., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291: 1701–12.Google ScholarPubMed
Rossouw, J. E., Anderson, G. L., Prentice, R. L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–33.Google ScholarPubMed
Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81–106.CrossRef
Diener, H. C., Cunha, L., Forbes, C., Sivenius, J., Smets, P., & Lowenthal, A.European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J. Neurol. Sci. 1996; 143: 1–13.CrossRefGoogle ScholarPubMed
The ESPS Group. The European Stroke Prevention Study (ESPS): principal end-points. Lancet 1987; 2: 1351–4.
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329–39.CrossRef
Diener, H. C., Bogousslavsky, J., Brass, L. M., et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 331–7.CrossRefGoogle ScholarPubMed
Bhatt, D. L., Fox, K. A. A., Hacke, W., et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N. Engl. J. Med. 2006; 354: 1706–17.CrossRefGoogle ScholarPubMed
Hart, R. G., Halperin, J. L., Pearce, L. A., et al. Lessons from the Stroke Prevention in Atrial Fibrillation trials. Ann. Intern. Med. 2003; 138: 831–8.CrossRefGoogle ScholarPubMed
Saxena, R. & Koudstaal, P.Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack. Cochrane Database Syst. Rev. 2004(4): CD000187.Google ScholarPubMed
Ferro, J. M.Cardioembolic stroke: an update. Lancet Neurol. 2003; 2: 177–88.CrossRefGoogle ScholarPubMed
Amarenco, P., Cohen, A., Tzourio, C., et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N. Engl. J. Med. 1994; 331: 1474–9.CrossRefGoogle ScholarPubMed
Blackshear, J. L., Zabalgoitia, M., Pennock, G., et al. Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation. SPAF transesophageal echocardiogram Investigators. Stroke Prevention and Atrial Fibrillation. Transesophageal echocardiography. Am. J. Cardiol. 1999; 83: 453–5, A9.CrossRefGoogle ScholarPubMed
Mohr, J. P.Anticoagulation for stroke prevention: yes, no, maybe. Cleve. Clin. J. Med. 2004; 71 (Suppl. 1): S52–6.CrossRefGoogle ScholarPubMed
Homma, S., Sacco, R. L., Di Tullio, M. R., Sciacca, R. R., & Mohr, J. P.Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002; 105: 2625–31.CrossRefGoogle ScholarPubMed
Chimowitz, M. I., Lynn, M. J., Howlett-Smith, H., et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N. Engl. J. Med. 2005; 352: 1305–16.CrossRefGoogle ScholarPubMed
Mohr, J. P., Thompson, J. L., Lazar, R. M., et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N. Engl. J. Med. 2001; 345: 1444–51.CrossRefGoogle ScholarPubMed
Levine, S. R., Brey, R. L., Tilley, B. C., et al. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004; 291: 576–84.Google ScholarPubMed
Chobanian, A. V., Bakris, G. L., Black, H. R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560–72.CrossRefGoogle ScholarPubMed
Dahlof, B., Devereux, R. B., Kjeldsen, S. E., et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995–1003.CrossRefGoogle ScholarPubMed
Psaty, B. M., Lumley, T., Furberg, C. D., et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003; 289: 2534–44.CrossRefGoogle ScholarPubMed
Barnett, H. J.Decision-making for carotid endarterectomy: the trials are only the start. Can. J. Neurol. Sci. 2002; 29: 302–4.CrossRefGoogle ScholarPubMed
Barnett, H. J., Taylor, D. W., Eliasziw, M., et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N. Engl. J. Med. 1998; 339: 1415–25.CrossRefGoogle ScholarPubMed
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273: 1421–8.CrossRef
Halliday, A., Mansfield, A., Marro, J., et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004; 363: 1491–502.Google ScholarPubMed
Yadav, J. S., Wholey, M. H., Kuntz, R. E., et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N. Engl. J. Med. 2004; 351: 1493–501.CrossRefGoogle ScholarPubMed
Rothwell, P. M., Eliasziw, M., Gutnikov, S. A., Warlow, C. P., & Barnett, H. J.Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363: 915–24.CrossRefGoogle ScholarPubMed
Rothwell, P. M., Eliasziw, M., Gutnikov, S. A., Warlow, C. P., & Barnett, H. J.Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke. Stroke 2004; 35: 2855–61.CrossRefGoogle ScholarPubMed
Bond, R., Rerkasem, K., & Rothwell, P. M.Systematic review of the risks of carotid endarterectomy in relation to the clinical indication for and timing of surgery. Stroke 2003; 34: 2290–301.CrossRefGoogle ScholarPubMed
Grubb, R. L. Jr., Powers, W. J., Derdeyn, C. P., Adams, H. P. Jr., & Clarke, W. R.The carotid occlusion surgery study. Neurosurg. Focus 2003; 14 (3): e9.CrossRefGoogle ScholarPubMed
Grubb, R. L. Jr., Derdeyn, C. P., Fritsch, S. M., et al. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998; 280: 1055–60.CrossRefGoogle ScholarPubMed
Vernieri, F., Pasqualetti, P., Passarelli, F., Rossini, P. M., & Silvestrini, M.Outcome of carotid artery occlusion is predicted by cerebrovascular reactivity. Stroke 1999; 30: 593–8.CrossRefGoogle ScholarPubMed
Yonemura, K., Kimura, K., Minematsu, K., Uchino, M., & Yamaguchi, T.Small centrum ovale infarcts on diffusion-weighted magnetic resonance imaging. Stroke 2002; 33: 1541–4.CrossRefGoogle ScholarPubMed
Landau, W. M.Clinical neuromythology VI. Au clair de lacune: holy, wholly, holey logic. Neurology 1989; 39: 725–30.CrossRefGoogle ScholarPubMed
Perry, H. M. Jr., Davis, B. R., Price, T. R., et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA 2000; 284: 465–71.CrossRefGoogle Scholar
Chen, C. J., Tseng, Y. C., Lee, T. H., Hsu, H. L., & See, L. C.Multisection computed tomography angiography compared with catheter angiography in diagnosing vertebral artery dissection. AJNR Am. J. Neuroradiol. 2004; 25: 769–74.Google ScholarPubMed
Touze, E., Gauvrit, J. Y., Moulin, T., Meder, J. F., Bracard, S., & Mas, J. L.Risk of stroke and recurrent dissection after a cervical artery dissection: a multicenter study. Neurology 2003; 61: 1347–51.CrossRefGoogle ScholarPubMed
Overell, J. R., Bone, I., & Lees, K. R.Interatrial septal abnormalities and stroke: a meta-analysis of case–control studies. Neurology 2000; 55: 1172–9.CrossRefGoogle ScholarPubMed
Messe, S. R., Silverman, I. E., Kizer, J. R., et al. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004; 62: 1042–50.CrossRefGoogle ScholarPubMed
Albers, G. W., Caplan, L. R., Easton, J. D., et al. Transient ischemic attack: proposal for a new definition. N. Engl. J. Med. 2002; 347: 1713–16.CrossRefGoogle ScholarPubMed
Johnston, S. C., Gress, D. R., Browner, W. S., & Sidney, S.Short-term prognosis after emergency department diagnosis of transient ischemic attack. JAMA 2000; 284: 2901–6.CrossRefGoogle Scholar
Johnston, S. C. & Sidney, S.Validation of a 4-point prediction rule to stratify short-term stroke risk after transient ischemic attack [abstract]. Stroke 2005; 36: 430. [Presentation, International Stroke Meeting, February 2006.]Google Scholar
Qureshi, A. I., Tuhrim, S., Broderick, J. P., Batjer, H. H., Hondo, H., & Hanley, D. F.Spontaneous intracerebral hemorrhage. N. Engl. J. Med. 2001; 344: 1450–60.CrossRefGoogle ScholarPubMed
Mendelow, A. D., Gregson, B. A., Fernandes, H. M., et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005; 365: 387–97.CrossRefGoogle ScholarPubMed
Broderick, J. P., Adams, H. P. Jr., Barsan, W., et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999; 30: 905–15.CrossRefGoogle ScholarPubMed
Brott, T., Broderick, J., Kothari, R., et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28: 1–5.CrossRefGoogle ScholarPubMed
Mayer, S. A., Brun, N. C., Begtrup, K., et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N. Engl. J. Med. 2005; 352: 777–85.CrossRefGoogle ScholarPubMed
Broderick, J. P., Brott, T. G., Duldner, J. E., Tomsick, T., & Huster, G.Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke 1993; 24: 987–93.CrossRefGoogle ScholarPubMed
Hemphill, J. C., Bonovich, D. C., Besmertis, L., Manley, G. T., & Johnston, S. C.The intracerebral hemorrhage score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001; 32: 891–7.CrossRefGoogle ScholarPubMed
Mayberg, M. R., Batjer, H. H., Dacey, R.et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994; 25: 2315–28.CrossRefGoogle ScholarPubMed
Molyneux, A., Kerr, R., Stratton, I., et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002; 360: 1267–74.CrossRefGoogle ScholarPubMed
Bergh, W. M., Algra, A., Kooten, F., et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 2005; 36: 1011–15.CrossRefGoogle ScholarPubMed
Longstreth, W. T. Jr., Nelson, L. M., Koepsell, T. D., & Belle, G.Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington. Neurology 1993; 43: 712–18.CrossRefGoogle ScholarPubMed
Kassell, N. F., Torner, J. C., Jane, J. A., Haley, E. C. Jr., & Adams, H. P.The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: surgical results. J. Neurosurg. 1990; 73: 37–47.CrossRefGoogle ScholarPubMed
International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: risk of rupture and risks of surgical intervention. N. Engl. J. Med. 1998; 339: 1725–33.CrossRef
Wiebers, D. O., Whisnant, J. P., Huston, J., et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003; 362: 103–10.CrossRefGoogle ScholarPubMed
Brainin, M., Olsen, T. S., Chamorro, A., et al. Organization of stroke care: education, referral, emergency management and imaging, stroke units and rehabilitation. European Stroke Initiative. Cerebrovasc. Dis. 2004; 17 (Suppl. 2): 1–14.CrossRefGoogle ScholarPubMed
Hack, W., Kaste, M., Bogousslavsky, J., et al. European Stroke Initiative Recommendations for Stroke Management: update 2003. Cerebrovasc. Dis. 2003; 16: 311–37.Google Scholar
Schwamm, L. H., Pancioli, A., Acker, J. E., et al. Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke 2005; 36: 690–703.Google ScholarPubMed
Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst. Rev. 2002 (1): CD000197.
Alberts, M. J., Hademenos, G., Latchaw, R. E., et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 2000; 283: 3102–9.CrossRefGoogle ScholarPubMed
Duncan, P. W., Zorowitz, R., Bates, B., et al.. Management of adult stroke rehabilitation care: a clinical practice guideline. Stroke 2005; 36: e100–43.CrossRefGoogle ScholarPubMed
Tepel, M., Giet, M., Schwarzfeld, C., Laufer, U., Liermann, D., & Zidek, W.Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N. Engl. J. Med. 2000; 343: 180–4.CrossRefGoogle ScholarPubMed
Kay, J., Chow, W. H., Chan, T. M., et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 2003; 289: 553–8.CrossRefGoogle ScholarPubMed
Merten, G. J., Burgess, W. P., Gray, L. V., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; 291: 2328–34.CrossRefGoogle ScholarPubMed
Barber, P. A., Demchuk, A. M., Zhang, J., & Buchan, A. M.Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early computed tomography Score. Lancet 2000; 355: 1670–4.CrossRefGoogle Scholar
Eastwood, J. D., Engelter, S. T., MacFall, J. F., Delong, D. M., & Provenzale, J. M.Quantitative assessment of the time course of infarct signal intensity on diffusion-weighted images. AJNR Am. J. Neuroradiol. 2003; 24: 680–7.Google ScholarPubMed
Parizel, P. M., Makkat, S., Miert, E., Goethem, J. W., Hauwe, L., & Schepper, A. M.Intracranial hemorrhage: principles of computed tomography and magnetic resonance imaging interpretation. Eur. Radiol. 2001; 11: 1770–83.CrossRefGoogle Scholar
Alexandrov, A. V.Cerebrovascular Ultrasound in Stroke Prevention and Treatment: Elmsford, NY; Oxford: Blackwell/Futura, 2004.CrossRefGoogle Scholar
Angeli, S., Del Sette, M., Beelke, M., Anzola, G. P., & Zanette, E.Transcranial Doppler in the diagnosis of cardiac patent foramen ovale. Neurol. Sci. 2001; 22: 353–6.CrossRefGoogle Scholar
Jauss, M. & Zanette, E.Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc. Dis. 2000; 10: 490–6.CrossRefGoogle ScholarPubMed
Toth, C. & Voll, C.Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke. Stroke 2002; 33: 670–4.CrossRefGoogle ScholarPubMed
Hillbom, M., Erila, T., Sotaniemi, K., Tatlisumak, T., Sarna, S., & Kaste, M.Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study. Acta Neurol. Scand. 2002; 106: 84–92.CrossRefGoogle ScholarPubMed
Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. A definition of irreversible coma. JAMA 1968; 205: 337–40.CrossRef
Teasdale, G. & Jennett, B.Assessment of coma and impaired consciousness: a practical scale. Lancet 1974; 2: 81–4.CrossRefGoogle ScholarPubMed
Hunt, W. E. & Hess, R. M.Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J. Neurosurg. 1968; 28: 14–20.CrossRefGoogle ScholarPubMed
Teasdale, G. M., Drake, C. G., Hunt, W., et al. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J. Neurol. Neurosurg. Psychiatry 1988; 51: 1457.CrossRefGoogle ScholarPubMed
Rankin, J.Cerebral vascular accidents in patients over the age of 60. Scott. Med. J. 1957; 2: 200–15.CrossRefGoogle ScholarPubMed
Bonita, R. & Beaglehole, R.Modification of Rankin scale: recovery of motor function after stroke. Stroke 1988; 19: 1497–500.CrossRefGoogle Scholar
Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J., & Gijn, J.Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604–7.CrossRefGoogle ScholarPubMed
Goldstein, L. B., Bertels, C., & Davis, J. N.Interrater reliability of the National Institutes of Health stroke scale. Arch. Neurol. 1989; 46: 660–2.CrossRefGoogle Scholar
Lyden, P., Raman, R., Liu, L., et al. National Institutes of Health Stroke Scale training and certification using a new digital video disk is reliable. Stroke 2005; 36: 2446–9.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • References
  • Ken Uchino, University of Texas, Houston, Jennifer Pary, University of Texas, Houston, James Grotta, University of Texas, Houston
  • Book: Acute Stroke Care
  • Online publication: 10 October 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545108.028
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • References
  • Ken Uchino, University of Texas, Houston, Jennifer Pary, University of Texas, Houston, James Grotta, University of Texas, Houston
  • Book: Acute Stroke Care
  • Online publication: 10 October 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545108.028
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • References
  • Ken Uchino, University of Texas, Houston, Jennifer Pary, University of Texas, Houston, James Grotta, University of Texas, Houston
  • Book: Acute Stroke Care
  • Online publication: 10 October 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545108.028
Available formats
×